Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
Background This cost analysis uses data from a randomized trial comparing a no prophylaxis versus prophylactic platelet (PLT) transfusion policy (counts <10 × 109/L) in adult patients with hematologic malignancies.
المؤلفون الرئيسيون: | Campbell, H, Estcourt, L, Stokes, E, Llewelyn, C, Murphy, M, Wood, E, Stanworth, S |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Blackwell Publishing Inc.
2014
|
مواد مشابهة
-
Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
حسب: Campbell, H, وآخرون
منشور في: (2014) -
Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
حسب: Stanworth, S, وآخرون
منشور في: (2014) -
Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
حسب: Stanworth, S, وآخرون
منشور في: (2014) -
Prophylactic platelet transfusions
حسب: Estcourt, L, وآخرون
منشور في: (2010) -
Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
حسب: Stanworth, S, وآخرون
منشور في: (2010)